SALMAN ALY: Open Payments
NPI 1326287715 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,044 in 28 payments from 7 companies in 2025. Trend: 2023 $1,335 · 2024 $1,701 · 2025 $1,044
Food & beverage: $1,044
| Company | Payments | Amount |
|---|---|---|
| MIMEDX Group, Inc. | 4 | $332 |
| ABBVIE INC. | 14 | $272 |
| REVANCE THERAPEUTICS, INC. | 5 | $241 |
| Smith+Nephew, Inc. | 1 | $104 |
| PFIZER INC. | 2 | $54 |
| Galderma Laboratories, L.P. | 1 | $24 |
| SHIELD THERAPEUTICS INC | 1 | $17 |
Products named: DAXXIFY, BOTOX, GRAFIX PL, AVYCAZ, DALVANCE, VYNDAQEL, ELIQUIS, UBRELVY.
Industry payments across TX — which companies pay providers there.
